Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Utopia SIS SpA is an Italian investment company focused on high-growth projects in the Life Sciences sector. Established to bridge the venture capital gap in Italy, the firm targets innovative startups that enhance collective well-being. Their portfolio includes six companies, emphasizing scientific merit and potential therapies.
Utopia SIS SpA invests in Seed and Series A stages, primarily within the Life Sciences sector. Their investment areas include Disease Modifying Drugs, Medical Devices, Diagnostic Tools and Biomarkers, and AI applications in healthcare. The firm seeks projects that develop therapies for unmet medical needs, prioritizing scientific merit in their evaluations.
Notable portfolio companies include Novavido Srl, PerFormS Srl, Lighthouse Biotech Srl, Drug Discovery and Clinic Srl, CaSRevolution Srl, and T-One Therapeutics Srl, all focusing on high-growth potential within the medical and scientific ecosystem.
Submit your pitch through their form at utopiasis.it or email info@utopiasis.it with your deck.
Yes, Utopia SIS SpA often leads investment rounds in the startups they back, particularly in the Seed and Series A stages.
The firm is open to follow-on investments, especially for companies that demonstrate significant growth and potential in the Life Sciences sector.
Specific details about the fund size are not disclosed, but the firm focuses on high-growth projects within the Life Sciences sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.